Ozempic isn’t Bad if Used for the Right Reasons

Updated on September 24, 2023

While Ozempic’s incredible potential for managing Type 2 diabetes has been well-documented, its ability to aid in weight loss has rapidly captured widespread media attention, though the Food and Drug Administration (FDA) has not yet reviewed or approved the drug for this purpose. When pharmaceuticals are promoted for non-FDA-approved purposes, public health concerns emerge.

That’s why anyone considering Ozempic should approach this medication responsibly. Individual experiences may vary, so consumers should inform themselves of this medication’s potential side effects as well as its benefits. Consulting a healthcare professional is also essential for safe and effective treatment.

Ozempic’s rise in popularity

Over 600 million searches for hashtags related to Ozempic and weight loss have hit social media platforms like TikTok. Even major news sources like CNN and The Washington Post have covered the story, and celebrity endorsements have further propelled the drug into mainstream conversations.

This heightened visibility can be viewed positively, as it raises public awareness about Type 2 diabetes and the obesity crisis plaguing the United States. It also opens discussions about the potential benefits of the medication — not only for Type 2 diabetes, but also for weight loss.

Such coverage democratizes access to important information and makes it easier for people to learn about different treatments and medications. This increased attention has helped drive home the importance of tackling these significant health challenges, and could potentially steer more research and resources in this direction.

However, the internet in general — and social media in particular — should never be a substitute for professional medical advice.

The right reasons to use Ozempic

Ozempic is approved for the treatment of Type 2 diabetes because it functions as a GLP-1 agonist, mimicking the effects of the gastrointestinal hormone GLP-1. When administered for the treatment of Type 2 diabetes, Ozempic helps regulate blood sugar levels and reduce glucose production in the liver. This helps maintain optimal blood sugar levels, which is an essential factor in effectively managing diabetes.

If you have Type 2 diabetes and need better glycemic control, Ozempic has proven to be one of the leading options to treat your condition, especially if your healthcare provider recommends it. But beyond this core function, Ozempic has also garnered attention for a noteworthy secondary benefit: weight loss. Although weight loss is not the medication’s primary intent, it serves as a welcome ancillary advantage for many patients.

When it comes to weight loss, Ozempic has not been granted FDA approval for this purpose, despite a very similar drug, WeGovy, already being FDA approved for weight loss. Nevertheless, users should remember that the current primary FDA-approved use for Ozempic is for the management of Type 2 diabetes, where it has already demonstrated strong capabilities.

Using Ozempic for weight loss

That said, using Ozempic for weight loss isn’t necessarily wrong. In many cases, healthcare professionals already prescribe this pharmaceutical for this purpose.

At the same time, any drug or medication being used for off-label purposes can have potential risks, as abuse of any substance can be dangerous to your health. Exercising caution and responsibility when using medications is not just advisable — it’s essential for your health and well-being.

With any medication, it’s always important to speak with a medical professional before deciding on treatment. Medications can have many different applications, so it’s critical to be informed of all your options. That’s why every patient should only use Ozempic under the supervision of a medical professional and at the proper dosage level — no matter if it’s used for Type 2 diabetes or weight loss.

If you’re contemplating using Ozempic for weight loss, it’s also vital to proceed with full awareness of the potential risks. This medication has some serious side effects that should not be overlooked, including thyroid cancer, pancreatitis, gallstones, and renal damage. That’s why it’s important to consult with a healthcare provider to determine if Ozempic is the right treatment for you based on your unique medical background.

While we await the FDA’s decision on Ozempic, the good news is that the drug’s popularity is already transforming the pharmaceutical industry for the better.

The Ozempic revolution

Due to the high demand for Ozempic, pharmaceutical companies are collaborating more than ever before. It’s heartening to see the concerted efforts of major companies like Novo Nordisk, AstraZeneca, and Eli Lilly working alongside regulatory agencies to study the drug and ensure patient safety. 

In addition, the high demand for this medication has also compelled pharmaceutical companies to refine their supply chain strategies. All eligible patients need access to their vital treatments on time, and the improvements companies make today promise benefits for the long term.

A moment of positive change

In the case of Ozempic, patient needs, corporate responsibility, and public attention are all in alignment. This creates a moment for tremendous positive change. 

The spotlight social media shines on Ozempic can promote informed discussions, responsible use, beneficial collaborations, and common-sense public policy. Regardless of how the FDA rules on this particular medication, millions of people stand to benefit as a result.

George Kramb
George Kramb
CEO and co-founder at PatientPartner

George Kramb is the CEO and co-founder of PatientPartner, a platform he created after recognizing the anxiety patients felt before medical procedures. With a background in supporting doctors in the operating room, George saw the need for more significant support, education, and compassion for patients facing stressful medical experiences. PatientPartner connects patients in a community of empathy and support, boasting over 100 PatientPartner Mentors who share their own medical experiences to help others. George, a Bachelor of Science in Economics graduate from the University of Oregon, has been featured in prestigious publications like Inc and Forbes 30 Under 30 for Consumer Technology and is a regular contributor to Entrepreneur. Under his leadership, PatientPartner has also built a network of over 50 doctors who prioritize improving their patients' experiences through connections with relatable individuals.